Praxis Precision Medicines
(NASDAQ) PRAX
Praxis Precision Medicines Financials at a Glance
Market Cap
$8.08B
Revenue (TTM)
$0.00
Net Income (TTM)
$303.27M
EPS (TTM)
$-13.47
P/E Ratio
-21.54
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$290.69
Volume
25,766
Open
$302.30
Price
$290.69
Volume
25,766
Open
$302.30
Previous Close
$290.69
Daily Range
$288.60 - $306.32
52-Week Range
$26.70 - $356.00
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$290.69
Volume
25,766
Open
$302.30
Previous Close
$290.69
Daily Range
$288.60 - $306.32
52-Week Range
$26.70 - $356.00
PRAX News
PRAX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Praxis Precision Medicines
Industry
Biotechnology
Sector
Health CareEmployees
168
CEO
Marcio Souza, MBA
Website
www.praxismedicines.comHeadquarters
Boston, MA 02110, US
PRAX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-46%
Return on Capital
-37%
Return on Assets
-32%
Earnings Yield
-4.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.08B
Shares Outstanding
27.85M
Volume
25.77K
Short Interest
0.00%
Avg. Volume
511.23K
Financials (TTM)
Gross Profit
$140.00K
Operating Income
$326.20M
EBITDA
$303.13M
Operating Cash Flow
$249.07M
Capital Expenditure
$56.00K
Free Cash Flow
$249.12M
Cash & ST Invst.
$599.33M
Total Debt
$110.00K
Praxis Precision Medicines Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$28.00K
+99.9%
Gross Margin
0.00%
N/A
Market Cap
$8.08B
N/A
Market Cap/Employee
$69.65M
N/A
Employees
116
N/A
Net Income
$88.91M
-51.5%
EBITDA
$88.88M
-39.1%
Quarterly Fundamentals
Net Cash
$599.22M
+53.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$110.00K
-91.3%
Return on Assets
-32.33%
N/A
Return on Invested Capital
-37.15%
N/A
Free Cash Flow
$77.26M
-37.7%
Operating Cash Flow
$77.26M
-37.7%